SELLAS Life Sciences Group, Inc. (FRA:RXK3)
Germany flag Germany · Delayed Price · Currency is EUR
1.286
+0.058 (4.72%)
At close: Nov 28, 2025

FRA:RXK3 Statistics

Total Valuation

FRA:RXK3 has a market cap or net worth of EUR 183.79 million. The enterprise value is 146.18 million.

Market Cap183.79M
Enterprise Value 146.18M

Important Dates

The next estimated earnings date is Wednesday, March 18, 2026.

Earnings Date Mar 18, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 142.44M
Shares Outstanding n/a
Shares Change (YoY) +82.98%
Shares Change (QoQ) +9.98%
Owned by Insiders (%) 0.26%
Owned by Institutions (%) 23.15%
Float 142.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 4.73
P/TBV Ratio 4.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -6.61
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.01.

Current Ratio 8.28
Quick Ratio 7.48
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -84.33% and return on invested capital (ROIC) is -55.90%.

Return on Equity (ROE) -84.33%
Return on Assets (ROA) -44.90%
Return on Invested Capital (ROIC) -55.90%
Return on Capital Employed (ROCE) -61.44%
Revenue Per Employee n/a
Profits Per Employee -1.47M
Employee Count15
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +17.12% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +17.12%
50-Day Moving Average 1.50
200-Day Moving Average 1.40
Relative Strength Index (RSI) 47.51
Average Volume (20 Days) 1,865

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 8.97

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -23.90M
Pretax Income -22.11M
Net Income -22.11M
EBITDA n/a
EBIT -23.90M
Earnings Per Share (EPS) -0.24
Full Income Statement

Balance Sheet

The company has 37.77 million in cash and 510,528 in debt, giving a net cash position of 37.26 million.

Cash & Cash Equivalents 37.77M
Total Debt 510,528
Net Cash 37.26M
Net Cash Per Share n/a
Equity (Book Value) 38.89M
Book Value Per Share 0.31
Working Capital 36.76M
Full Balance Sheet

Cash Flow

Operating Cash Flow -26.10M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

FRA:RXK3 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -82.98%
Shareholder Yield -82.98%
Earnings Yield -12.03%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 8, 2019. It was a reverse split with a ratio of 0.02.

Last Split Date Nov 8, 2019
Split Type Reverse
Split Ratio 0.02

Scores

Altman Z-Score n/a
Piotroski F-Score 1